A new series of HCV inhibitors based on a 2-(thieno[2,3b]pyridin-2-yl)-1,3,4-oxadiazole scaffold

Weiqiong Zuo(Sichuan University), Luoting Yu(State Key Laboratory of Biotherapy), Kai Ran(Chongqing University of Arts and Sciences), Chao Gao(Sichuan University), Xinyu You(State Key Laboratory of Biotherapy), Kun-Jie Xiao(Sichuan University), Li Liu(Sichuan University), Zhihao Liu(Sichuan University), Lidan Zhang(Sichuan University), Yongxia Zhu(University of Electronic Science and Technology of China), Cuiting Peng(Sichuan University), Hong Tang(Sichuan University), Ningyu Wang(Southwest Jiaotong University)
RSC Advances
January 1, 2016
Cited by 14


Related Papers